BSN

BSN encodes Bassoon, a large (~420 kDa) neuron-specific protein that localizes to the cytoskeletal matrix at presynaptic neurotransmitter release sites, where it serves as a structural scaffold organizing the active zone (PMID:10329005). Beyond its scaffolding role, Bassoon acts together with the E3 ubiquitin ligase PRKN/parkin to restrain presynaptic macroautophagy; its loss reduces synaptic vesicle pool size and impairs vesicle recycling, defects that are reversed by PRKN knockdown (PMID:32718208). Cell-type-specific ablation reveals divergent circuit functions: loss in GABAergic interneurons reduces inhibitory synaptic vesicle numbers and synaptic efficacy, diminishes hippocampal inhibition, reconfigures network activity, and produces ASD- and epilepsy-related behavioral phenotypes, whereas loss in glutamatergic forebrain neurons paradoxically increases cortical activity and accelerates learning [PMID:bio_10.1101_2025.11.20.689526, PMID:bio_10.1101_2025.11.24.690204]. BSN mutations also disrupt astrocyte lipid homeostasis—elevating cholesterol and lipid droplets, upregulating APOE and FASN, and impairing Kir4.1 channel function—driving neuronal hyperexcitability and apoptosis in co-culture (PMID:40962686). Protein-truncating and predicted loss-of-function variants in BSN cause adult-onset, non-syndromic obesity, with iPSC-derived hypothalamic neuron studies implicating degenerative impairment of synaptic function as the mechanism (PMID:38575728, PMID:37865656).

1. 1998 Medium

   The initial cloning established BSN as a brain-restricted gene encoding a very large multidomain protein, raising the question of where in the neuron it acts.

   Evidence cDNA cloning, sequencing, Northern blot, RT-PCR, and chromosomal mapping to 3p21

   PMID:9806829

   Open questions at the time

   • Early sequence-based inference proposed a nuclear/transcriptional role that was not borne out
   • No subcellular localization data in this study
   • No functional assay of the encoded protein
2. 1999 Medium

   Characterization of the ~420 kDa protein placed Bassoon at presynaptic release sites, defining it as a member of an emerging presynaptic cytomatrix protein family.

   Evidence Genomic cloning, FISH localization, sequencing, and primary structure analysis identifying it as a presynaptic cytoskeletal component

   PMID:10329005

   Open questions at the time

   • Mechanistic role at the active zone not yet defined
   • Binding partners not identified
   • No loss-of-function phenotype established
3. 2020 Medium

   Genetic epistasis demonstrated that Bassoon controls presynaptic autophagy and vesicle pool maintenance through PRKN/parkin, providing a molecular mechanism for its scaffolding role.

   Evidence shRNA knockdown of PRKN in BSN-deficient primary neurons with SV pool size, protein level, and recycling readouts

   PMID:32718208

   Open questions at the time

   • Direct biochemical interaction between Bassoon and PRKN not detailed here
   • Single lab, cultured-neuron system
   • Whether this pathway operates identically across neuron types unaddressed
4. 2023 High

   Population-scale sequencing linked BSN haploinsufficiency to a human disease, establishing predicted loss-of-function variants as a cause of non-syndromic obesity.

   Evidence Exome-wide association in ~140,000 UK Biobank individuals with replication in All of Us WGS

   PMID:37865656

   Open questions at the time

   • Causal cell type and circuit not resolved by genetics alone
   • Mechanism connecting synaptic protein loss to body weight not established here
5. 2024 High

   Functional studies in iPSC-derived hypothalamic neurons connected BSN protein-truncating variants to obesity via degenerative impairment of synaptic function, and showed PTVs amplify common polygenic BMI risk.

   Evidence Exome sequencing in up to 587,027 individuals, iPSC-derived hypothalamic neuron studies, and plasma proteomics

   PMID:38575728

   Open questions at the time

   • Precise hypothalamic circuit and neuropeptide pathway affected unspecified
   • In vivo validation of the degenerative mechanism not provided
6. 2024 Medium

   A knock-in mouse carrying a patient-corresponding BSN missense mutation linked a specific allele to dopaminergic neurodegeneration and cognitive/motor deficits, distinguishing missense from loss-of-function consequences.

   Evidence CRISPR knock-in mouse (Bsn p.P3882A) with Y-maze, locomotor testing, and immunohistochemistry for Bassoon and dopaminergic markers

   PMID:39130376

   Open questions at the time

   • Molecular basis of dopaminergic neuron vulnerability unresolved
   • Absence of tau accumulation leaves the degenerative pathway undefined
   • Single mutation, single model
7. 2025 Medium

   CRISPR-edited human iPSC astrocytes revealed a non-neuronal disease mechanism: BSN mutations disrupt astrocyte lipid homeostasis and Kir4.1 function, non-cell-autonomously driving neuronal hyperexcitability and damage.

   Evidence CRISPR/Cas9 patient-mutation knock-in in iPSC-derived astrocytes with lipid assays, proteomics, electrophysiology, and neuron co-culture

   PMID:40962686

   Open questions at the time

   • How Bassoon, a presynaptic protein, regulates astrocyte lipid metabolism is unexplained
   • In vivo relevance not tested
   • Single lab
8. 2025 Medium

   Cell-type-specific conditional knockouts dissected opposing circuit roles, showing GABAergic loss impairs inhibition and learning while glutamatergic loss enhances cortical activity and learning, with minimal effect from dopaminergic loss.

   Evidence Conditional KO mice (Dlx5/6, Emx1, DAT Cre lines) with electrophysiology, SPECT imaging, histology, behavior, and network recordings (preprints)

   PMID:bio_10.1101_2025.11.20.689526 PMID:bio_10.1101_2025.11.24.690204

   Open questions at the time

   • Preprint status, single lab
   • Molecular basis for divergent excitatory vs inhibitory outcomes not resolved
   • Connection to the human obesity and neurodegeneration phenotypes not established

• How a single presynaptic scaffold reconciles its divergent cell-type-specific circuit effects, its astrocytic lipid role, and its causal contribution to human obesity remains unresolved.
• No unifying molecular mechanism links presynaptic scaffolding to systemic body-weight regulation
• Structural and interaction maps of Bassoon's functional domains are absent from the corpus
• In vivo validation of the astrocyte lipid mechanism is lacking